Table 1 Population analysis
| Â | Non DM (35) | DM (56) | p value |
|---|---|---|---|
Sex (male, %) | 28 (80.0) | 36 (64.3) | NS |
Age (years) | 70.7 ± 9.4 | 70.4 ± 5.9 | NS |
MAP (mmHg) | 97 ± 12 | 96 ± 12 | NS |
BMI (kg/m2) | 27.7 ± 4.2 | 30.9 ± 4.6 | < 0.001 |
Positive family history (n, %) | 17 (48.6) | 25 (44.6) | NS |
History of hypertension (n, %) | 30 (85.7) | 49 (87.5) | NS |
Hyperlipidaemia (n, %) | 16 (45.7) | 39 (69.6) | 0.04 |
Current smoking (n, %) | 9 (25.7) | 9 (16.1) | NS |
Total pack years | 32.7 ± 34.4 | 17.1 ± 22.2 | < 0.001 |
COPD (n, %) | 3 (8.6) | 6 (10.7) | NS |
Known CAD (n, %) | 12 (34.3) | 20 (35.7) | NS |
Previous PCI (n, %) | 11 (31.4) | 14 (25.0) | NS |
Previous CABG (n, %) | 1 (2.9) | 2 (3.6) | NS |
Angina (CCS class) | 1.9 ± 1.1 | 2.3 ± 0.7 | NS |
Dyspnoe (NYHA class) | 1.6 ± 1.1 | 2.1 ± 0.8 | NS |
Duration of diabetes (years) | NA | 11.9 ± 9.4 | NA |
Diabetic retinopathy (n, %) | NA | 10 (17.9) | NA |
Diabetic polyneuropathy (n, %) | NA | 20 (35.7) | NA |
Total cholesterol (mg/dl) | 195.3 ± 43.8 | 191.2 ± 45.1 | NS |
LDL-cholesterol (mg/dl) | 128.9 ± 39.6 | 117.8 ± 36.4 | NS |
HDL-cholesterol (mg/dl) | 48 ± 13.2 | 44.2 ± 10.3 | NS |
HbA1c (%) | 5.7 ± 0.4 | 7.2 ± 1.6 | < 0.001 |
Medication prior to coronary angiography | |||
 ASA (n, %) | 31 (88.6) | 52 (92.9) | NS |
 ACEi/ARB (n, %) | 24 (65.7) | 40 (71.4) | NS |
 β-Blocker (n, %) | 24 (65.7) | 46 (82.1) | NS |
 Statine (n, %) | 21 (60.0) | 35 (62.5) | NS |